iHealthScreen has received $2.7M in NIH funding, raised $750K as seed funding, and has established partnerships with key industry players. The company has achieved CE certification for AMD, DR, and glaucoma screening and is developing prediction models for strokes, heart attacks, and cardiovascular diseases.
iHealthScreen is an AI-driven HIPAA-compliant med-tech company specializing in Scalably Screening for Retinal Diseases, Stroke, and Heart Disease using AI technology. The company aims to prevent blindness, save lives, and reduce downstream healthcare costs through early diagnosis and intervention. iHealthScreen is in the pre-revenue stage of development.